| J0897 | Injection, denosumab, 1 mg | 8,290 | $20 | $149.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 1,020 | $90 | $90.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,000 | $80 | $75.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 71,250 | $1 | $71.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 510 | $120 | $61.3K |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 8,100 | $10 | $40.5K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 6,040 | $10 | $36.3K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,360 | $10 | $32.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $110 | $26.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 160 | $160 | $25K |